DCAT Value Chain Insights

President Biden Announces Plan for Drug-Pricing Reform

President Joe Biden has released a plan for drug-pricing reform in the US. One of the key measures is to allow the federal government to negotiate drug prices under Medicare, the healthcare program...

CDMOs Invest in Biomanufacturing, Cell- & Gene-Therapy Manufacturing

Biomanufacturing is an active area of investment by CDMOs with several large expansions by Samsung Biologics, Fujifilm Diosynth, Boehringer Ingelheim, and Lonza. Other CDMOs (Catalent, Thermo...

SPONSORED CONTENT

Monoclonal Antibody Manufacturing for BioPharma: To Build or Outsource?

Information
September 8, 2021
Sponsored by Samsung Biologics

As the global biologics market continues to grow, securing speed with scale has never been a greater priority. Here we demonstrate important factors to consider in making optimal outsourcing...

Read More
Feeling Pressure To Shorten Early Development Timelines?

Information
August 11, 2021
Sponsored by Thermo Fisher Scientific

Lengthy early-development timelines are common across new and emerging biotech companies for a multitude of reasons. Striking the right balance of speed, quality, risk, and investment allows you to...

Read More
Expand Opportunities with a Strong CMO Relationship

Information
July 28, 2021
Sponsored by CMIC CMO USA

Pharmaceutical and biopharmaceutical companies have been extensively using contract research organizations (CROs) to meet their challenging needs in R&D and standard work for several decades. A...

Read More